News
STAT viewed a draft of legislation to link U.S. drug prices to those in other countries that two people familiar with the ...
Tebipenem's approval in 2026 under SPA could bring Spero $400M+ in milestones & royalties. Read more on why SPRO is a Buy, ...
Nektar Therapeutics' REZPEG shows progress in treating atopic dermatitis & alopecia areata. Click here to find out why I rate NKTR stock a Buy.
A salmonella egg recall and falling prices highlight a deeper truth: trust in the food system is slower to recover than the ...
Opponents of price controls brought on by the Biden administration and the $891 billion Inflation Reduction Act of 2022 have ...
Several trade groups want to repeal a portion of the Inflation Reduction Act and prevent the federal government from setting prescription drug prices.
Appetite-suppressing drugs could wipe out millions of fast-food trips. What it means for your choices and your money.
A lawsuit by the Dayton Area Chamber of Commerce challenging federal government drug price controls in the Inflation ...
A recent poll showing American dissatisfaction with prescription drug companies is no surprise. The cost of medications is among the public’s biggest gripes about health care.
The U.S. Food and Drug Administration said on Wednesday it has approved Nuvation Bio's therapy for patients with a type of ...
President Trump's executive order seeking to tie U.S. drug prices to those abroad could impact future investment in Am ...
At the Special Meeting, Onconetix's stockholders approved the following proposals: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results